Tenderwize
Retour à la recherche

Open-House Supply Agreement for Therapy Allergens for Subcutaneous Immunotherapy

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 552 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Therapie-Allergene zur subkutanen Immuntherapie, ATC V01AA02

62/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

62 / 100

Complexité

48 / 100

Facteurs de risque

Contract documents must be submitted through the DTVP communications area and not through the offer area; using the wro...

Participation is limited to pharmaceutical companies and requires a signed reliability declaration; missing this would...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Non-exclusive open-house supply arrangement for therapy allergens for subcutaneous immunotherapy (ATC V01AA02).
  • Contract terms are pre-set and not individually negotiable.
Afficher le résumé complet

This is an open-house supply arrangement by AOK Bayern for pharmaceutical products (therapy allergens for subcutaneous immunotherapy, ATC V01AA02). It is explicitly described as not a standard competitive procurement, with identical non-exclusive contracts offered to all interested pharmaceutical companies meeting the stated suitability requirement. No contract value is provided. Submission is through DTVP or by paper originals in duplicate, with bilingual constraint to German and mandatory German translation for non-German documents. The notice is highly specific on contract start/end timing and monthly cut-off dates.

Risques

Contract documents must be submitted through the DTVP communications area and not through the offer area; using the wro...

Participation is limited to pharmaceutical companies and requires a signed reliability declaration; missing this would...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible as potential contractual partners.

Administrative

  • Submit a signed reliability self-declaration.
  • Submit the signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-House Supply Agreement for Therapy Allergens for Subcutaneous Immunotherapy

Open-house non-exclusive supply contract for therapy allergens for subcutaneous immunotherapy (ATC V01AA02). Scope is defined in the contract and related annexes downloadable from the tender documents. The notice says only pharmaceutical companies may become contractual partners. Lot information is from structured data and notice text.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Apr 2026 - Apr 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 03, 2028

Détails de la procédure

Date de publication
15 Mar 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
179863-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30